Mukka Proteins has issued a corrigendum for its postal ballot notice regarding a ₹47 crore preferential issue of 2 crore convertible warrants. Proceeds will fund working capital and expansion.
Mukka Proteins Seeks ₹47 Crore Via Preferential Warrant Issue
Mukka Proteins Limited has issued a corrigendum to its postal ballot notice concerning a proposed preferential issue of 2 crore convertible warrants, aiming to raise ₹47 crore. The company clarified this update addresses observations from the National Stock Exchange and BSE, emphasizing that material terms like the issue price and allottees remain unchanged.
What just happened
The company is seeking shareholder approval via postal ballot for the preferential issuance of 2 crore convertible warrants at ₹23.50 per warrant, aggregating ₹47 crore. This follows a corrigendum to the notice, clarifying details for exchanges.
Why this matters
This preferential issue will provide Mukka Proteins with crucial funds to strengthen its working capital by ₹35 crore and support business expansion with ₹5 crore. The remaining ₹7 crore is allocated for general corporate purposes, facilitating growth and operational stability.
The backstory
The issue price of ₹23.50 per warrant is set above the regulatory floor price of ₹23.18 (based on 90-day VWAP) and the independent valuer's fair value of ₹18.14 per share. This pricing suggests a premium valuation.
What changes now
Shareholders who have already voted can modify their votes by contacting the scrutinizer by July 12, 2026, if they wish to reconsider based on the corrigendum's clarifications.
Risks to watch
Investors should monitor the timely and efficient utilization of the raised funds, as the company plans to deploy them within 24 months for working capital and expansion.
Peer comparison
While not explicitly stated in the filing, similar preferential issues by listed companies are often used to fund growth initiatives or manage debt. Mukka Proteins' focus on working capital suggests a need for operational liquidity.
Context metrics (time-bound)
The total aggregation from the issue is ₹47 crore, comprising 2 crore warrants at ₹23.50 each. Proceeds are to be utilized within 24 months.
What to track next
Investors should closely follow the outcome of the postal ballot and the subsequent allotment of warrants, along with the company's progress in utilizing the funds for its stated objectives.